Tag: Medicines

Posted on

Empowering Biomedical Research in Rural West Virginia

by
0 comments

Public health crises often disproportionately impact rural America. Sally L. Hodder, M.D., works to alleviate these disparities, especially regarding the opioid crisis and the COVID-19 pandemic. She’s the director of the West Virginia Clinical and Translational Science Institute (WVCTSI), the associate vice president of clinical and translational research, and a professor of medicine at West Virginia University.

A headshot of Dr. Sally Hodder.
Dr. Sally Hodder. Credit: West Virginia University.

Dr. Hodder’s work is focused in West Virginia, but her results are valuable assets to researchers across the country. Not only does treating chronic diseases in rural populations contribute to the overall understanding of those diseases, but engaging with and involving people in those communities in research makes science more accessible to them. Dr. Hodder says, “When folks participate in the science, when there is good community discussion about the trial designs and the results, then I think those populations may be more trusting of the results.”

Continue reading “Empowering Biomedical Research in Rural West Virginia”
Posted on

Career Conversations: Q&A with Bioengineer César de la Fuente

by
0 comments
Headshot of Dr. de la Fuente.
Dr. César de la Fuente. Credit: Martí E. Berenguer.

“Science provides adventure and excitement every single day. When you’re pushing boundaries, you get to jump into the abyss of new areas. It can be scary, but it’s an incredible opportunity to try to improve our world and people’s lives,” says César de la Fuente, Ph.D., a Presidential Assistant Professor in the Perelman School of Medicine and School of Engineering and Applied Science at the University of Pennsylvania, Philadelphia. Our interview with Dr. de la Fuente highlights his journey of becoming a scientist and his research using artificial intelligence to discover new drugs.

Q: How did you first become interested in science?

A: I’ve always been fascinated by the world around me. I grew up in a town in northwest Spain, right on the Atlantic Ocean. As a kid, I would go to the beach to investigate marine organisms and bring home all sorts of different fish to study. My mom wasn’t too happy about that! We’re all born scientists, but we tend to lose that curiosity as we enter adulthood. The key is to not lose our ability to learn every day.

Continue reading “Career Conversations: Q&A with Bioengineer César de la Fuente”
Posted on

Career Conversations: Q&A with Organic Chemist Elizabeth Parkinson

by
0 comments
Dr. Parkinson wearing a lab coat and gloves and holding a Petri dish.
Dr. Elizabeth Parkinson. Credit: Courtesy of Dr. Elizabeth Parkinson.

“Being able to discover new, unexpected things is why you wake up every day and go to work as a scientist. The other part is hopefully to have a positive impact on human health—through combatting conditions ranging from antibiotic resistance to cancer,” says Elizabeth Parkinson, Ph.D., an assistant professor of organic chemistry at Purdue University in West Lafayette, Indiana. In an interview, Dr. Parkinson shared with us her path to a scientific career, research on natural products made by soil-dwelling bacteria, and advice for students.

Q: What sparked your interest in science?

A: My high school freshman biology teacher, Mr. O’Connell, first got me interested in science. He’d bring objects to class, and we’d have to guess how they might relate to the day’s subject matter. One time he brought strawberries, and we isolated DNA from them, which I really enjoyed. I also participated in a science fair for the first time that year. My project focused on how the color of light affected plant growth, and that was a very fun experience.

Continue reading “Career Conversations: Q&A with Organic Chemist Elizabeth Parkinson”
Posted on

Science Snippet: Lipids in the Limelight

by
0 comments
A large blue oval surrounded by small yellow circles.
Spheres of lipids (yellow) inside a cell. The nucleus is shown in blue. Credit: James Olzmann, University of California, Berkeley.

Have you ever wondered why your cells don’t spill into each other or what keeps your skin separate from your blood? The answer to both is lipids—a diverse group of organic compounds that don’t dissolve in water. They’re one of the four major building blocks of our bodies, along with proteins, carbohydrates, and nucleic acids. Types of lipids include:

  • Fats, necessary for our bodies’ long-term energy storage and insulation. Some essential vitamins are fat soluble, meaning they must be associated with fat molecules to be effectively absorbed.
  • Phospholipids, which make up a large part of cell and organelle membranes.
  • Waxes, which help protect delicate surfaces. For instance, earwax protects the skin of the ear canal.
  • Steroids, including cholesterol, a precursor to many hormones, which helps maintain the fluidity of cell membranes.
Continue reading “Science Snippet: Lipids in the Limelight”
Posted on

Three Brothers Are Making Research a Family Affair

by
0 comments
From left to right: Caleb, Paul, and Adam Worsley sitting on stools in a chemistry lab.
Caleb, Paul, and Adam Worsley. Credit: Pittsburg State University.

“You’re doing something really important with people who are important to you,” Paul Worsley remarks when asked about having his younger brothers Caleb and Adam as lab mates. The trio are undergraduate students working in the lab of Santimukul Santra, Ph.D., at Pittsburg State University in Pittsburg, Kansas.

Paul seated at his chemistry fume hood. Credit: Pittsburg State University.

All three brothers are part of the Kansas IDeA Networks of Biomedical Research Excellence (K-INBRE). Paul is currently a junior majoring in biology and history. He plans to go to medical school when he graduates, but his time in the lab has given him a love for research—and has even led him to toy with the idea of going to graduate school instead. His twin brothers Caleb and Adam are only freshmen, but they both think they want to pursue scientific research when they graduate.

When Paul was a sophomore, he applied for a K-INBRE research spot in Dr. Santra’s lab and was immediately accepted. He quickly realized that organic chemistry in the lab was much different—and more exciting—than anything he’d seen in the classroom. “I like organic synthesis because it really tests your knowledge,” he says. “Answering exam questions is way different than actually doing it in a lab.” Despite the challenges that came with research, Paul was clearly doing great work because one day Dr. Santra joked, “Hey, you got any brothers?” Paul responded, “Actually, yes.”

Continue reading “Three Brothers Are Making Research a Family Affair”
Posted on

In Other Words: Some Antagonists Are Heroes

by
1 comment

Many of us learned in English class that an antagonist is a person or thing that a hero fights. But in biomedical science, an antagonist is a molecule that binds to a cellular receptor to prevent a response, such as a muscle contraction or hormone release. Antagonists can be important medical treatments, like the antagonist naloxone—also known as Narcan —that can reverse an opioid overdose.

Below the title “Antagonist: In Other Words,” two images are separated by a jagged line. On the left is a dark figure with a hat, and on the right is an antagonist bound to a ribbon model depiction of a receptor. Under the images, text reads: “Did you know? In biomedical science, an antagonist is a molecule that binds to a cellular receptor to prevent a response, such as a muscle contraction or hormone release.” 
Credit: NIGMS; Yekaterina Kadyshevskaya, The Scripps Research Institute.
Continue reading “In Other Words: Some Antagonists Are Heroes”
Posted on

Discovering Better Ways to Build Medicinal Molecules

by
2 comments
Dr. Baran standing in front of a chemistry fume hood with molecular structures drawn on it.
Dr. Phil Baran. Credit: Scripps Research.

“I love the mystery of chemistry. It explores the great unknown of the universe,” says Phil Baran, Ph.D., a professor of chemistry at Scripps Research, La Jolla, California. His passion for the subject catalyzed a successful career in organic synthesis—building molecules that are the foundation of living things and can be developed as medicines.

Setting His Sights on Science

School didn’t interest Dr. Baran until he found chemistry in 10th grade. “From there, the mission was clear: do whatever was required to do chemistry for the rest of my life,” he says. At the time, that meant achieving certain grades, so he focused on improving his academic performance. He also took courses at a community college and graduated with his high school diploma and associate degree simultaneously.

Continue reading “Discovering Better Ways to Build Medicinal Molecules”
Posted on

COVID-19 Vaccine and Therapeutic Trials ACTIV-ate in West Virginia

by
0 comments
Hands in medical gloves drawing liquid from a vial into a syringe with a model of SARS-CoV-2 in the background. ACTIV clinical trials will evaluate the safety and efficacy of COVID-19 treatments and vaccines. Credit: iStock.

Since the virus that causes COVID-19, known as SARS-CoV-2, was first reported in late 2019, scientists have launched hundreds of studies on strategies for diagnosis, prevention, and treatment. To prioritize the most promising vaccine and therapeutics candidates, streamline clinical trials, and coordinate regulatory processes, the National Institutes of Health (NIH) and the Foundation for the NIH have established the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership. ACTIV brings together eight government entities, 20 biopharmaceutical companies, and four nonprofit organizations.

The public-private partnership provides infrastructure, subject matter expertise, and funding to efficiently bring the most promising therapeutics and vaccines into clinical trials. Five ACTIV therapeutic trials are underway. NIGMS-supported Institutional Development Award Program Infrastructure for Clinical and Translational Research (IDeA-CTR) networks reach historically underserved areas and populations, which are important participants in such trials.

Continue reading “COVID-19 Vaccine and Therapeutic Trials ACTIV-ate in West Virginia”
Posted on

Career Conversations: Q&A with Organic Chemist Osvaldo Gutierrez

by
1 comment

Osvaldo Gutierrez, Ph.D., was born in Rancho Los Prietos, a small town in central Mexico where his grandmother served as a midwife. Seeing how his grandmother helped people through her work inspired Dr. Gutierrez to pursue a career where he, too, could help people. His family emigrated to the United States when he was young. Despite challenges he faced in a new country, he graduated from high school, attended community college, and was accepted to the University of California, Los Angeles. He originally planned to become a medical doctor, but an undergraduate research experience sparked an interest in chemistry, and he ultimately earned a Ph.D. in the field.

Continue reading “Career Conversations: Q&A with Organic Chemist Osvaldo Gutierrez”
Posted on

Pathways: The Superbug Issue

by
1 comment
Cover of Pathways student magazine showing blueish-green virus particles and text that reads, Stop the Spread of Superbugs (Yes, you can help!). Cover of Pathways student magazine.

NIGMS and Scholastic bring you our latest issue of Pathways, which focuses on superbugs—infectious microbes that can’t be fought off with medicines. Viruses that can’t be prevented with vaccines, such as the common cold, and antibiotic-resistant bacteria both fall into this category.

Pathways, designed for students in grades 6 through 12, is a collection of free resources that teaches students about basic science and its importance to health, as well as exciting research careers.

Continue reading “Pathways: The Superbug Issue”